Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: Clinical and laboratory evaluation()

Recombinant-Feline Interferon-Omega (rFeIFN-ω) is an immune-modulator licensed for use subcutaneously in Feline Immunodeficiency virus (FIV) therapy. Despite oral protocols have been suggested, little is known about such use in FIV-infected cats. This study aimed to evaluate the clinical improvement...

Descripción completa

Detalles Bibliográficos
Autores principales: Gil, S., Leal, R.O., McGahie, D., Sepúlveda, N., Duarte, A., Niza, M.M.R.E., Tavares, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111837/
https://www.ncbi.nlm.nih.gov/pubmed/24332273
http://dx.doi.org/10.1016/j.rvsc.2013.11.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111837/
https://www.ncbi.nlm.nih.gov/pubmed/24332273
http://dx.doi.org/10.1016/j.rvsc.2013.11.007

Ejemplares similares